ARCHIVES

Afinitor Approved for Rare Disorder

This article is from The Cancer Letter archive.

Vol. 36 No. 40 | November 5, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Tipping Resigned Forom ACS Following Volunteer Discontent

September 27, 1991

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

NCI May Support More Training Of Cancer Surgeons

May 23, 1975

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014